Tag: PARP inhibitors
Triple-Negative Breast Cancer: Modern Treatment Strategies and Ongoing Clinical Trials
- By : Tamsin Riverton
- Date : Jan 28 2026
Triple-negative breast cancer (TNBC) is aggressive and hard to treat, but new therapies like immunotherapy, PARP inhibitors, and personalized vaccines are changing outcomes. Learn the latest treatment strategies and clinical trials shaping care in 2026.
